{"title":"Growth \u0026 Performance","description":"GH secretagogue peptides including Ipamorelin, CJC-1295, GHRP-6, and Tesamorelin — studied for their role in growth hormone release pathways, body composition research, and anabolic signalling. For laboratory and research use only.","products":[{"product_id":"tesamorelin","title":"Tesamorelin","description":"\u003cp\u003e\u003cspan\u003eGHRH analog; strongest visceral\/abdominal fat burner, clean GH\/IGF-1 boost\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e (also known as \u003cstrong\u003eTH9507\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic 44-amino-acid polypeptide\u003c\/strong\u003e analog of human \u003cstrong\u003egrowth hormone-releasing hormone\u003c\/strong\u003e (\u003cstrong\u003eGHRH\u003c\/strong\u003e), featuring an N-terminal modification with a \u003cstrong\u003etrans-3-hexenoyl\u003c\/strong\u003e group for enhanced stability and resistance to enzymatic degradation. This research compound has garnered significant scientific interest for its ability to stimulate pulsatile endogenous \u003cstrong\u003egrowth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) secretion from the anterior pituitary, thereby elevating \u003cstrong\u003einsulin-like growth factor-1\u003c\/strong\u003e (\u003cstrong\u003eIGF-1\u003c\/strong\u003e) levels and influencing metabolic pathways. Preliminary and advanced preclinical studies indicate that tesamorelin may promote lipolysis, reduce visceral adipose tissue, support muscle preservation, and modulate body composition. Researchers employ this peptide in laboratory and animal models to investigate mechanisms of GH axis regulation, fat metabolism, and endocrine responses, particularly in models of metabolic dysregulation and age-related decline. As a research-grade compound, tesamorelin is intended exclusively for in vitro and animal studies. Scientists value its improved pharmacokinetic profile over native GHRH and its utility in elucidating targeted GH stimulation without direct exogenous hormone administration.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eVisceral Adipose Tissue Reduction\u003c\/strong\u003e — Preclinical and clinical-model studies demonstrate that tesamorelin significantly decreases visceral fat accumulation through enhanced lipolysis and triglyceride reduction. It has been extensively investigated in models of HIV-associated lipodystrophy and central obesity, showing preferential effects on abdominal fat while preserving subcutaneous adipose tissue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Hormone Axis Stimulation\u003c\/strong\u003e — Tesamorelin potently activates GHRH receptors to induce pulsatile GH release and elevate IGF-1 levels. Research explores its role in restoring GH secretion in states of relative deficiency, including aging, metabolic syndrome, and antiretroviral therapy-related endocrine disruption.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody Composition and Muscle Health\u003c\/strong\u003e — Investigations reveal tesamorelin's potential to increase lean muscle area and density in truncal muscle groups, while improving muscle quality metrics (e.g., Hounsfield units) in models of sarcopenia and fat infiltration. Studies assess its anabolic effects alongside fat loss for better overall body composition.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic and Lipid Profile Modulation\u003c\/strong\u003e — Tesamorelin favorably influences lipid metabolism, insulin sensitivity, and energy balance in preclinical models. Research examines its impact on triglycerides, liver fat, and metabolic parameters in obesity and diabetes-related contexts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroader Endocrine and Protective Effects\u003c\/strong\u003e — Emerging studies probe its applications in neuroprotection, cardiovascular health, and age-related metabolic decline, with implications for investigating GH-mediated anabolic and lipolytic pathways across multiple organ systems.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₂₂₁H₃₆₆N₇₂O₆₇S\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: 5135.9 g\/mol (free base)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence\u003c\/strong\u003e: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ (C-terminal amidation)\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Omni Peptides","offers":[{"title":"10mg","offer_id":50413275873527,"sku":"TSM10","price":500.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/ts-10mg.png?v=1768028138"},{"product_id":"ipamorelin","title":"Ipamorelin","description":"\u003cp\u003e↑ GH\/IGF-1, better sleep \u0026amp; recovery, body recomposition\u003c\/p\u003e\n\u003cp style=\"white-space: pre-wrap;\" dir=\"auto\"\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e is a \u003cstrong\u003esynthetic pentapeptide\u003c\/strong\u003e and highly selective \u003cstrong\u003egrowth hormone secretagogue\u003c\/strong\u003e (GHS) that functions as a potent agonist of the \u003cstrong\u003eghrelin receptor\u003c\/strong\u003e (GHS-R1a). This research compound has attracted substantial scientific interest due to its ability to stimulate pulsatile \u003cstrong\u003eendogenous growth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) release from the anterior pituitary with minimal impact on other hormones such as prolactin, cortisol, or adrenocorticotropic hormone (ACTH). Preliminary and advanced preclinical studies indicate that Ipamorelin may promote lipolysis, support lean body mass, enhance recovery processes, and exhibit favorable pharmacokinetic properties including high selectivity and stability. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of GH axis modulation, body composition, tissue repair, and age-related endocrine changes. As a research-grade compound, Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its clean pharmacological profile, lack of significant appetite stimulation compared to other GHS compounds, and utility in advancing understanding of selective ghrelin receptor agonism in anabolic and metabolic research.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Hormone Secretion and Pulsatility\u003c\/strong\u003e — Preclinical investigations demonstrate that Ipamorelin elicits robust, dose-dependent, and pulsatile GH release via specific activation of pituitary GHS-R1a receptors. Studies highlight its ability to mimic natural GH pulses while avoiding the broad hormonal perturbations seen with non-selective secretagogues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody Composition and Anabolic Effects\u003c\/strong\u003e — Research shows Ipamorelin promotes increases in lean muscle mass, improves nitrogen balance, and supports protein synthesis in various animal models. It has been explored for potential benefits in sarcopenia, cachexia, and recovery from catabolic states.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFat Metabolism and Lipolysis\u003c\/strong\u003e — Ipamorelin enhances lipolytic activity and reduces fat accumulation in preclinical obesity and metabolic models, often in combination with other peptides. Investigations assess its role in improving body composition without inducing significant hyperglycemia or insulin resistance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair and Recovery\u003c\/strong\u003e — Studies indicate potential benefits in accelerating wound healing, tendon and cartilage repair, and bone metabolism through elevated GH\/IGF-1 axis activity. Research explores its applications in models of injury, aging, and post-surgical recovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeuroprotection and Cognitive Support\u003c\/strong\u003e — Emerging preclinical data suggest neuroprotective properties, including possible modulation of brain-derived neurotrophic factor (BDNF) and improved outcomes in models of neurodegeneration, traumatic brain injury, and age-related cognitive decline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₃₈H₄₉N₉O₅\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: 711.85 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence\u003c\/strong\u003e: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid; D-2-Nal = D-2-naphthylalanine; C-terminal amidation)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"10mg","offer_id":50432781517047,"sku":"IP10","price":320.0,"currency_code":"AED","in_stock":true},{"title":"5mg","offer_id":50432784007415,"sku":"IP5","price":210.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/ipa-5mg.png?v=1768562575"},{"product_id":"ghrp-6","title":"GHRP-6","description":"\u003cp\u003eImproves insulin sensitivity, endurance, metabolic health and hunger increase\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eGHRP-6\u003c\/strong\u003e (Growth Hormone Releasing Peptide-6) is a \u003cstrong\u003esynthetic hexapeptide\u003c\/strong\u003e and potent \u003cstrong\u003egrowth hormone secretagogue\u003c\/strong\u003e that acts as an agonist of the \u003cstrong\u003eghrelin receptor\u003c\/strong\u003e (GHS-R1a). This research compound has attracted substantial scientific interest for its strong stimulation of \u003cstrong\u003eendogenous growth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) release from the anterior pituitary, as well as its unique ability to markedly increase appetite via central hypothalamic pathways. Preliminary and advanced preclinical studies indicate that GHRP-6 may promote pulsatile GH secretion, enhance IGF-1 levels, support anabolic processes, accelerate tissue repair, and influence energy balance through both GH-dependent and GH-independent mechanisms. Researchers utilize GHRP-6 in laboratory and animal models to investigate mechanisms of GH axis activation, ghrelin signaling, appetite regulation, wound healing, and metabolic responses in contexts of growth, aging, catabolic states, and recovery. As a research-grade compound, GHRP-6 is intended exclusively for in vitro and animal studies. Scientists value its robust GH-releasing potency, pronounced orexigenic (appetite-stimulating) effect, and utility in studying the interplay between ghrelin receptor activation, growth hormone dynamics, and feeding behavior.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Hormone Secretion and Pulsatility\u003c\/strong\u003e — Preclinical investigations demonstrate that GHRP-6 elicits strong, dose-dependent, and pulsatile GH release through specific activation of GHS-R1a receptors on pituitary somatotrophs and via hypothalamic pathways. It synergizes powerfully with GHRH analogs to produce supra-additive GH pulses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppetite Stimulation and Feeding Behavior\u003c\/strong\u003e — GHRP-6 is one of the most potent orexigenic peptides known, markedly increasing food intake and hunger signaling in animal models via direct activation of arcuate nucleus NPY\/AgRP neurons. Research frequently uses it to study central mechanisms of appetite regulation and ghrelin mimetics.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnabolic Effects and Body Composition\u003c\/strong\u003e — Studies show GHRP-6 promotes nitrogen retention, increases lean body mass, and supports protein synthesis in various catabolic and recovery models. It has been investigated for potential benefits in sarcopenia, cachexia, muscle wasting, and post-injury anabolic support.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair and Wound Healing\u003c\/strong\u003e — Research indicates accelerated healing of skin wounds, tendons, ligaments, and bone in preclinical injury models, attributed to elevated GH\/IGF-1 levels, improved collagen deposition, and enhanced local growth factor expression.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic and Protective Effects\u003c\/strong\u003e — GHRP-6 influences glucose homeostasis, insulin sensitivity (with both acute and chronic effects under study), and cardioprotection in ischemia-reperfusion models. Investigations also explore its roles in counteracting catabolic states, modulating immune function, and protecting against oxidative stress in various tissues.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₄₆H₅₆N₁₂O₆\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: 873.01 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence\u003c\/strong\u003e: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ (C-terminal amidation; contains D-amino acids at positions 2 and 5 for enhanced stability)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"10mg","offer_id":50722550579447,"sku":null,"price":200.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/ghrp6_10mg.png?v=1777543757"},{"product_id":"cjc-1295","title":"CJC-1295 NO DAC (Mod GRF 1-29)","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eCJC-1295 No DAC\u003c\/strong\u003e (also known as \u003cstrong\u003eMod GRF (1-29)\u003c\/strong\u003e or \u003cstrong\u003etetrasubstituted GRF (1-29)\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic 29-amino-acid polypeptide\u003c\/strong\u003e analog of \u003cstrong\u003egrowth hormone-releasing hormone\u003c\/strong\u003e (\u003cstrong\u003eGHRH\u003c\/strong\u003e), featuring four strategic amino acid substitutions (at positions 2, 8, 15, and 27) designed to dramatically enhance stability and resistance to enzymatic degradation compared to native GHRH. Unlike the DAC-containing version, CJC-1295 No DAC has a short half-life (approximately 6–8 minutes), resulting in more physiological, pulsatile stimulation of endogenous \u003cstrong\u003egrowth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) secretion. This research compound has attracted significant scientific interest for its potent and selective activation of pituitary somatotropes. Preliminary and advanced preclinical studies indicate that CJC-1295 No DAC may robustly increase GH and \u003cstrong\u003eIGF-1\u003c\/strong\u003e levels in a natural pulsatile pattern, support anabolic processes, enhance recovery, and promote favorable changes in body composition. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of GH axis physiology, pulsatile hormone release, tissue repair, and age-related endocrine modulation. As a research-grade compound, CJC-1295 No DAC is intended exclusively for in vitro and animal studies. Scientists value its clean pharmacokinetic profile, minimal off-target hormonal effects, and utility in studying natural GH pulsatility versus sustained release patterns.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulsatile Growth Hormone Secretion\u003c\/strong\u003e — Preclinical investigations demonstrate that CJC-1295 No DAC elicits strong, dose-dependent, and naturally pulsatile GH release by activating GHRH receptors on pituitary somatotrophs. Studies emphasize its ability to mimic physiological GH secretion patterns more closely than long-acting analogs, preserving feedback regulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody Composition and Anabolic Research\u003c\/strong\u003e — Research shows increases in lean body mass, improvements in nitrogen retention, and enhanced protein synthesis in various animal models. It has been explored for potential applications in sarcopenia, cachexia, muscle wasting, and post-injury recovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic Secretagogue Combinations\u003c\/strong\u003e — CJC-1295 No DAC is frequently studied in combination with GHS compounds (e.g., Ipamorelin, GHRP-6) to achieve synergistic amplification of GH pulses, resulting in greater overall GH\/IGF-1 output while maintaining selectivity and minimizing side effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFat Metabolism and Lipolysis\u003c\/strong\u003e — Investigations indicate enhanced lipolytic activity and reductions in fat mass in preclinical obesity and metabolic models, often attributed to elevated GH levels and improved insulin sensitivity in certain contexts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair and Recovery\u003c\/strong\u003e — Studies suggest benefits in accelerating wound healing, tendon\/ligament repair, cartilage regeneration, and bone metabolism through GH\/IGF-1-mediated pathways. Research explores its role in models of aging, traumatic injury, and surgical recovery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₁₅₂H₂₅₂N₄₄O₄₂\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: 3367.9 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence\u003c\/strong\u003e: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (C-terminal amidation; key substitutions: D-Ala², Gln⁸, Ala¹⁵, Leu²⁷)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"5mg","offer_id":50722256650487,"sku":null,"price":250.0,"currency_code":"AED","in_stock":false},{"title":"10mg","offer_id":50722256683255,"sku":"CND10","price":400.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/modgrf129_5mg.png?v=1777536871"},{"product_id":"klow-blend","title":"KLOW Blend","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eKLOW Blend\u003c\/strong\u003e (also known as \u003cstrong\u003eKlow Stack\u003c\/strong\u003e or \u003cstrong\u003eRadiance Recovery Blend\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic multi-peptide formulation\u003c\/strong\u003e combining \u003cstrong\u003eBPC-157\u003c\/strong\u003e, \u003cstrong\u003eTB-500\u003c\/strong\u003e (Thymosin Beta-4), \u003cstrong\u003eKPV\u003c\/strong\u003e, and \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e in a single lyophilized vial (commonly totaling 80 mg, with typical ratios such as BPC-157 10 mg, TB-500 10 mg, KPV 10 mg, GHK-Cu 50 mg). This research blend has garnered significant attention in preclinical regenerative studies for its synergistic potential to address tissue repair, inflammation resolution, immune modulation, and extracellular matrix remodeling through complementary pathways. It builds on simpler blends like Wolverine (BPC-157 + TB-500) by incorporating KPV for enhanced anti-inflammatory effects and GHK-Cu for collagen synthesis and dermal\/tissue rejuvenation. Researchers employ KLOW Blend in laboratory and animal models to investigate multi-target regenerative mechanisms, particularly in injury recovery, chronic inflammation, wound healing, and age-related tissue decline. As a research-grade compound, KLOW Blend is intended exclusively for in vitro and animal studies. Scientists value its broad-spectrum approach, combining cytoprotective, angiogenic, actin-regulatory, and copper-mediated signaling for comprehensive tissue restoration research.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Tissue and Musculoskeletal Regeneration\u003c\/strong\u003e — Preclinical models show the blend accelerates repair of muscles, tendons, ligaments, skin, and connective tissues. BPC-157 and TB-500 drive angiogenesis and cell migration, while GHK-Cu supports collagen deposition and matrix remodeling, often yielding enhanced biomechanical recovery in injury and overuse paradigms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Inflammatory and Immune Modulation\u003c\/strong\u003e — KPV potently suppresses pro-inflammatory cytokines (e.g., TNF-α, IL-6) and NF-κB signaling, complementing the cytoprotective and resolution-promoting actions of the other components. Studies explore efficacy in models of chronic inflammation, autoimmune-like conditions, gastrointestinal insults, and systemic inflammatory states.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWound Healing and Dermal Repair\u003c\/strong\u003e — The combination promotes re-epithelialization, granulation tissue formation, reduced scarring, and improved collagen organization. GHK-Cu's role in extracellular matrix synthesis synergizes with TB-500's cell motility and BPC-157's growth factor modulation, making it a focus in cutaneous, surgical, and chronic wound models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSystemic Recovery and Anti-Aging Effects\u003c\/strong\u003e — Investigations highlight benefits in metabolic support, oxidative stress reduction, mitochondrial function preservation, and overall tissue resilience. The blend is studied for potential in age-related decline, post-exercise recovery, and multi-organ protection (e.g., gut, skin, musculoskeletal).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic Multi-Pathway Mechanisms\u003c\/strong\u003e — Research examines how the four peptides interact to amplify regenerative outcomes beyond individual administration, including enhanced VEGF pathways, actin dynamics, copper-dependent enzyme activity, and melanocortin-mediated inflammation control.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Blend of BPC-157 (C₆₂H₉₈N₁₆O₂₂; MW 1419.5 g\/mol), TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S; MW 4963.5 g\/mol), KPV (C₁₆H₃₀N₄O₄; MW 342.43 g\/mol), GHK-Cu (C₁₄H₂₂CuN₆O₄; MW 401.9 g\/mol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: Composite (varies by exact ratio; approximately 6,000–7,000 g\/mol for standard formulations).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequences\u003c\/strong\u003e:\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\u003c\/li\u003e\n\u003cli\u003eTB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/li\u003e\n\u003cli\u003eKPV: Lys-Pro-Val\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: Gly-His-Lys (complexed with Cu²⁺)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"Default Title","offer_id":50432797409527,"sku":"KLOW80","price":1150.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/klow_80mg.png?v=1771307398"},{"product_id":"cjc-ipa-blend","title":"IPA\/CJC Blend","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eCJC-1295 No DAC + Ipamorelin\u003c\/strong\u003e (often called the \u003cstrong\u003e“Gold Standard” GH-releasing combo\u003c\/strong\u003e or \u003cstrong\u003eCJC\/Ipa blend\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic peptide combination\u003c\/strong\u003e pairing \u003cstrong\u003eCJC-1295 without DAC\u003c\/strong\u003e (Modified GRF 1-29) with \u003cstrong\u003eIpamorelin\u003c\/strong\u003e, typically provided in a single lyophilized vial (common ratios include 5 mg CJC-1295 No DAC + 5 mg Ipamorelin, 2 mg\/2 mg, or 10 mg total blends). This research formulation has become one of the most widely studied and utilized growth hormone secretagogue stacks in preclinical models due to its potent synergistic stimulation of \u003cstrong\u003eendogenous pulsatile growth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) release while maintaining a remarkably clean side-effect profile. CJC-1295 No DAC acts as a GHRH analog to amplify GH pulse amplitude, while Ipamorelin functions as a selective ghrelin mimetic (GHS-R1a agonist) to increase pulse frequency and potency, resulting in supra-additive GH\/IGF-1 elevation. Researchers employ this blend in laboratory and animal models to investigate mechanisms of GH axis physiology, body composition optimization, tissue repair, metabolic regulation, and age-related endocrine decline. As a research-grade compound, CJC-1295 No DAC + Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its near-physiological pulsatile GH pattern, minimal impact on cortisol\/prolactin, lack of significant appetite stimulation, and exceptional synergy for studying maximal endogenous GH output without exogenous hormone administration.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulsatile Growth Hormone and IGF-1 Amplification\u003c\/strong\u003e — Preclinical studies consistently demonstrate that the combination produces dramatically higher GH peaks and greater total GH\/IGF-1 area-under-the-curve compared to either peptide alone. The synergy mimics youthful, multi-pulse GH secretion patterns while preserving negative feedback regulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody Composition and Anabolic Research\u003c\/strong\u003e — The blend promotes increases in lean muscle mass, improved nitrogen retention, enhanced protein synthesis, and reductions in fat mass in various animal models. It is frequently investigated in sarcopenia, cachexia, muscle wasting, post-injury recovery, and age-related body composition decline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFat Metabolism and Lipolysis\u003c\/strong\u003e — Research shows enhanced lipolytic activity, increased fatty acid oxidation, and preferential reduction in visceral and subcutaneous fat depots, often attributed to elevated GH pulses and improved metabolic flexibility without significant insulin resistance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair and Recovery\u003c\/strong\u003e — The combination accelerates healing of muscle, tendon, ligament, cartilage, and bone injuries in preclinical models. Studies explore benefits in wound healing, connective tissue regeneration, post-surgical recovery, and counteracting catabolic states through elevated GH\/IGF-1 axis activity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Aging and Metabolic Health\u003c\/strong\u003e — Investigations highlight potential improvements in insulin sensitivity (in certain dosing contexts), bone density, skin elasticity, sleep quality, and overall vitality markers. The clean profile makes it a favored tool for studying long-term GH restoration effects in aging and metabolic syndrome models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Blend of CJC-1295 No DAC (C₁₅₂H₂₅₂N₄₄O₄₂; MW 3367.9 g\/mol),  Ipamorelin (C₃₈H₄₉N₉O₅; MW 711.85 g\/mol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: Composite (~4,080 g\/mol for equal parts).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequences\u003c\/strong\u003e:\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eCJC-1295 No DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (C-terminal amidation; substitutions: D-Ala², Gln⁸, Ala¹⁵, Leu²⁷)\u003c\/li\u003e\n\u003cli\u003eIpamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid; D-2-Nal = D-2-naphthylalanine; C-terminal amidation)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"10 mg (5+5)","offer_id":50436630872311,"sku":null,"price":400.0,"currency_code":"AED","in_stock":true},{"title":"18 mg (12+6)","offer_id":50436630905079,"sku":null,"price":600.0,"currency_code":"AED","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/ipa_cjc_10mg_38526b14-2f36-4f57-a044-9afa8b117429.png?v=1768806275"}],"url":"https:\/\/dubaipeptides.ae\/collections\/growth-performance.oembed","provider":"Dubai Peptides","version":"1.0","type":"link"}